{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:41:25Z","timestamp":1765294885088,"version":"build-2065373602"},"reference-count":20,"publisher":"Wiley","issue":"14","license":[{"start":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2017,7,15]]},"abstract":"<jats:p>High\u2010risk mutations are associated with poor response to interferon\u2010\u03b12. Early treatment with interferon\u2010\u03b12 is recommended in patients who have early myelofibrosis without high\u2010risk mutations.<\/jats:p><jats:p>See also pages 2680\u20107.<\/jats:p>","DOI":"10.1002\/cncr.30676","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T11:07:37Z","timestamp":1495105657000},"page":"2600-2603","source":"Crossref","is-referenced-by-count":5,"title":["Molecular profiling as a novel tool to predict response to interferon\u2010\u03b12 in MPNs: The proof of concept in early myelofibrosis"],"prefix":"10.1002","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3936-8032","authenticated-orcid":false,"given":"Hans Carl","family":"Hasselbalch","sequence":"first","affiliation":[{"name":"Department of Hematology Zealand University Hospital Roskilde Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,5,18]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1987.tb00762.x"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)92656-0"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00320164"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.11.63"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1205::AID-CNCR21>3.0.CO;2-8"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050554"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11486"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23018"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.280"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.06.002"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.90"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07745.x"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-320069"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2015.93"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30679"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.119"},{"journal-title":"Exp Rev Hematol.","article-title":"Minimal residual disease or cure in MPN? Rationales and perspectives on combination therapy with interferon\u2010alpha2 and ruxolitinib","author":"Bjorn ME","key":"e_1_2_4_18_1"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.12.69"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/102476"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.12"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.30676","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.30676","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T15:59:54Z","timestamp":1760284794000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.30676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":20,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017,7,15]]}},"alternative-id":["10.1002\/cncr.30676"],"URL":"https:\/\/doi.org\/10.1002\/cncr.30676","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"type":"print","value":"0008-543X"},{"type":"electronic","value":"1097-0142"}],"subject":[],"published":{"date-parts":[[2017,5,18]]}}}